Filing summary
Entity and period: The supplied filing is Sarcos Technology and Robotics Corporation’s Form 10-K for the fiscal year ended December 31, 2022, filed March 16, 2023. This does not match the request metadata naming Palladyne AI Corp.; the filing text does not explain that discrepancy. Sarcos describes a robotics business focused on mobile robotic systems and solutions, including the Guardian XM, XT and Sea Class. The 2022 results include RE2, acquired April 25, 2022, only from its acquisition date.
Financial performance and position
| Metric | FY 2022 | FY 2021 |
|---|---|---|
| Revenue | $14.6 million | $5.1 million |
| Product development contract revenue | $14.2 million | $3.6 million |
| Product revenue | $0.3 million | $1.5 million |
| Gross profit and gross margin | $3.0 million; 20.3% | $1.2 million; 23.8% |
| Operating loss | $177.0 million | $81.0 million |
| Net loss | $157.1 million | $81.5 million |
| Net loss per share | $1.07 | $0.72 |
| Cash used in operating activities | $65.4 million | $42.1 million |
At December 31, 2022, cash and cash equivalents were $35.2 million and marketable securities were $79.3 million, totaling $114.5 million. Working capital was $118.6 million. Total liabilities were $23.2 million, including $13.3 million of operating lease liabilities; the company reported no outstanding debt. Cash, cash equivalents and marketable securities were down from $217.1 million at year-end 2021. The company had $3.5 million of remaining performance obligations, most expected to be recognized within 12 months.
Material changes versus prior year
- Revenue rose 187%, primarily because RE2 contributed product-development contract revenue after its acquisition. Product revenue fell 78% as Sarcos reduced sales of legacy products while focusing on core-product commercialization.
- Operating expenses more than doubled to $191.6 million. Research and development increased to $34.1 million, and the company recorded a $70.2 million non-cash goodwill impairment in the fourth quarter, fully impairing goodwill recognized in the RE2 acquisition.
- Net loss increased to $157.1 million. Other income included a $13.4 million gain from revaluation of warrant liabilities; the $3.9 million tax benefit was principally related to the RE2 acquisition and deferred tax valuation allowance.
- Investing cash outflow was $109.0 million, including $29.7 million net cash used for the RE2 acquisition and net purchases of marketable securities. Financing cash outflow was $7.5 million, including $8.1 million used for shares withheld to cover employee tax obligations.
Outlook, risks and notable items
- Management expected negative operating cash flow to continue until 2025 at the earliest. It said available liquidity was sufficient for at least 12 months from the report date, while also noting potential additional financing needs and an expectation to seek financing to bolster reserves. It reported no current plan for an equity financing in 2023.
- Management anticipated delivery of Guardian XM and XT systems beginning in the first half of 2023 and initial Sea Class deliveries in the second half of 2023. The Guardian XO required further development, including weight reduction and safety enhancements; commercial production was not expected before 2024.
- The company had begun engagement with a contract manufacturer but did not expect high-volume production capability from the partner until at least year-end 2023. It estimated internal capacity of 300–500 systems in 2023, depending on product mix, and did not expect to use all of it.
- Commercial demand remained unproven: Sarcos reported no binding customer sales contracts for commercial versions of its core products, despite discussions and customer interest. It shifted from a planned Robot-as-a-Service emphasis to upfront product sales; software upgrades and capabilities may also be sold or licensed.
- Major risks include commercialization and production delays, supply constraints and sole-source components, customer adoption, safety and product-liability exposure, financing needs, and successful integration of RE2. The company had $36.0 million in unconditional Palantir purchase commitments, including $8.0 million due in 2023, and $17.2 million in minimum lease payments.
- On January 23, 2023, Nasdaq notified the company that its share price had fallen below the $1 minimum bid requirement. The initial compliance deadline was July 22, 2023; the filing says a reverse split was among options under consideration. This is a reported, time-sensitive listing risk, not a statement of current status.
- The auditor issued an unqualified opinion on the financial statements. Management concluded disclosure controls and internal control over financial reporting were effective at December 31, 2022; the independent auditor did not attest to internal-control effectiveness. Management excluded RE2 from its internal-control evaluation.
Investor verification priorities
- Confirm the issuer and security identity: the request names Palladyne AI Corp., while the filing is for Sarcos Technology and Robotics Corporation (ticker STRC).
- Check subsequent filings for actual cash use, financing, liquidity runway and progress toward positive operating cash flow.
- Verify commercial deliveries, binding orders, revenue mix and customer concentration against the company’s 2023 outlook; three customers accounted for 74% of 2022 revenue.
- Track manufacturing-partner ramp-up, supply availability, product safety testing and any changes to commercialization timelines.
- Review subsequent Nasdaq listing notices and any actions taken to regain compliance, as well as the consequences of potential share issuance or equity-award dilution.